<DOC>
	<DOCNO>NCT01379053</DOCNO>
	<brief_summary>The zNose® MRSA test non-invasive breath test marker Staphylococcus aureus , may predict probability bacterial organism anterior naris , throat respiratory tract , wound , anus therefore able replace supplement current active Methicillin Resistant Staphylococcus Aureus ( MRSA ) surveillance effort . It consist : - A collection apparatus collection volatile compound suspect infection site onto sorbent trap Tedlar bag , well collection separate sample room air . - Analysis volatile organic compound suspect infection site room air short acoustic wave gas chromatography . - Interpretation volatile organic compound proprietary algorithm order predict probability Staphylococcus aureus infection colonization . This study test hypothesis identify presence MRSA sample `` head space '' culture medium anterior nare sample provide patient MRSA . Additionally , study test hypothesis identify presence MRSA sample air exhale nostril ( nasal exhalant ) .</brief_summary>
	<brief_title>Volatile Organic Compounds Staphylococcus Aureus Patients</brief_title>
	<detailed_description />
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>Suspicion staphylococcus aureus infection colonization Able give sample zNose® analysis Inability provide sample zNose® analysis</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Methicillin-resistant staphylococcus aureus</keyword>
	<keyword>Nosocomial disease</keyword>
	<keyword>Electronic nose</keyword>
	<keyword>Gas chromatography</keyword>
</DOC>